
|Articles|March 11, 2022
Choose Eurofins’ new state-of-the-art aseptic sterile fill/finish for clinical supplies
Author(s)Eurofins BioPharma Product Testing
Industry changes, such as shorter timelines and increased product complexity, can often introduce additional risks to the sterile fill/finish process, resulting in production delays, additional costs, and safety concerns.
Trending on Pharmaceutical Technology
1
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
2
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
3
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
4
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
5